×
About 163,515 results

ALLMedicine™ Myocardial Infarction Center

Research & Reviews  75,479 results

Walking on a thin line between potent platelet inhibition for myocardial infarction and...
https://doi.org/10.5603/CJ.2021.0032
Cardiology Journal; Laurencet ME, Iglesias JF et. al.

Apr 21st, 2021 - Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage.|2021|Laurencet ME,Iglesias JF,Noble S,Tessitore E,Degrauwe S,|

The Association of a PRECISE-DAPT Score With No-Reflow in Patients With ST-Segment Elev...
https://doi.org/10.1177/00033197211010602
Angiology Selçuk M, Çınar T et. al.

Apr 21st, 2021 - This study aimed to evaluate the association of admission PREdicting bleeding Complications In patients undergoing Stent implantation and subsEquent Dual Anti Platelet Therapy (PRECISE-DAPT) score with the development of no-reflow (NR) in patients...

Sex differences in investigations and outcomes among patients with type 2 myocardial in...
https://doi.org/10.1136/heartjnl-2021-319118
Heart (British Cardiac Society); Kimenai DM, Lindahl B et. al.

Apr 21st, 2021 - Type 2 myocardial infarction (MI) is a heterogenous condition and whether there are differences between women and men is unknown. We evaluated sex differences in clinical characteristics, investigations and outcomes in patients with type 2 MI. In ...

see more →

Guidelines  211 results

Screening for Asymptomatic Carotid Artery Stenosis
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening
US Preventative Services Task Force (USPSTF)

Feb 1st, 2021 - Carotid artery stenosis is atherosclerotic disease that affects extracranial carotid arteries. Asymptomatic carotid artery stenosis refers to stenosis in persons without a history of ischemic stroke, transient ischemic attack, or other neurologic ...

2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement o...
https://doi.org/10.1016/j.cjca.2020.04.004
The Canadian Journal of Cardiology; Deyell MW, AbdelWahab A et. al.

Jun 16th, 2020 - This Canadian Cardiovascular Society position statement is focused on the management of sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) that occurs in patients with structural heart disease (SHD), including previous myocar...

Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Stat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173829
Journal of the American College of Cardiology; Mahmud E, Dauerman HL et. al.

Apr 24th, 2020 - The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has resulted in a new and lethal disease termed coronavirus disease-2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, ...

Exercise-Related Acute Cardiovascular Events and Potential Deleterious Adaptations Following Long-Term Exercise Training: Placing the Risks Into Perspective–An Update: A Scientific Statement From t...
https://www.ahajournals.org/doi/10.1161/CIR.0000000000000749
Circulation Franklin BA,et al

Feb 25th, 2020 - Epidemiological and biological plausibility studies support a cause-and-effect relationship between increased levels of physical activity or cardiorespiratory fitness and reduced coronary heart disease events. These data, plus the well-documented ...

Cardiovascular and Autonomic Responses to Energy Drinks—Clinical Implications
https://www.mdpi.com/2077-0383/9/2/431/htm
Journal of Clinical Medicine; Somers KR,et al

Feb 4th, 2020 - There is an increasing consumption of energy drinks both in the United States and worldwide. The components of these beverages are sometimes unclear but commonly include caffeine, sugars, taurine, and B-vitamins. Young people, particularly those e...

see more →

Drugs  1,869 results see all →

Clinicaltrials.gov  80,909 results

Walking on a thin line between potent platelet inhibition for myocardial infarction and...
https://doi.org/10.5603/CJ.2021.0032
Cardiology Journal; Laurencet ME, Iglesias JF et. al.

Apr 21st, 2021 - Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage.|2021|Laurencet ME,Iglesias JF,Noble S,Tessitore E,Degrauwe S,|

The Association of a PRECISE-DAPT Score With No-Reflow in Patients With ST-Segment Elev...
https://doi.org/10.1177/00033197211010602
Angiology Selçuk M, Çınar T et. al.

Apr 21st, 2021 - This study aimed to evaluate the association of admission PREdicting bleeding Complications In patients undergoing Stent implantation and subsEquent Dual Anti Platelet Therapy (PRECISE-DAPT) score with the development of no-reflow (NR) in patients...

Sex differences in investigations and outcomes among patients with type 2 myocardial in...
https://doi.org/10.1136/heartjnl-2021-319118
Heart (British Cardiac Society); Kimenai DM, Lindahl B et. al.

Apr 21st, 2021 - Type 2 myocardial infarction (MI) is a heterogenous condition and whether there are differences between women and men is unknown. We evaluated sex differences in clinical characteristics, investigations and outcomes in patients with type 2 MI. In ...

see more →

News  5,043 results

Arterial Thromboembolism Risk Varies Across Cancer Types, Ages
https://www.medscape.com/viewarticle/949662

Apr 20th, 2021 - Patients with cancer face an increased risk of arterial thromboembolic events, including myocardial infarction (MI) and stroke, and for some that risk appears substantial, according to a new population-based study. For example, the 6-month inciden...

COVID Plus MI Confers Poor Prognosis; 1 in 3 Die in Hospital
https://www.medscape.com/viewarticle/949598

Apr 19th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 patients with ST-segment elevation myocardial infarction (STEMI) represent a high-risk population with unique demographic and clinical fe...

A 'Mess' of a Diagnosis: Is it Type 2 MI or a Nonischemic Imposter?
https://www.medscape.com/viewarticle/949458

Apr 15th, 2021 - Survival gains in the management of acute myocardial infarction (MI) in recent decades don't apply to one increasingly common category of MI. Type 2 MI, triggered by a surge in myocardial oxygen demand or a drop in its supply, is on the rise and m...

Arthritis Drug May Curb Myocardial Damage in Acute STEMI
https://www.medscape.com/viewarticle/949160

Apr 11th, 2021 - Early use of tocilizumab (Actemra) does not reduce myocardial infarct size but modestly increases myocardial salvage in patients with acute ST-segment elevation myocardial infarction (STEMI), results of the ASSAIL-MI trial suggest. "We're among th...

Long Work Hours Tied to Double the Risk for Recurrent MI
https://www.medscape.com/viewarticle/948717

Apr 4th, 2021 - Patients who work upward of 55 hours per week after a myocardial infarction (MI) may increase their risk of having a recurrence, a new study suggests. Over a 6-year period, investigators studied close to 1000 patients younger than 60 years who ret...

see more →

Patient Education  4 results see all →